We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FL
276
DELISTED
Foot Locker
FL
$8.88M 0.06%
+130,836
New +$6.22M
KEY icon
277
KeyCorp
KEY
$24.1B
$8.85M 0.06%
382,468
-17,749
-4% -$412K
MAA icon
278
Mid-America Apartment Communities
MAA
$16B
$8.83M 0.06%
38,479
+31,652
+464% +$6.54M
GSKY
279
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$8.81M 0.06%
775,396
+600
+0.1% +$7.04K
MGNX icon
280
MacroGenics
MGNX
$238M
$8.79M 0.06%
547,729
-60,794
-10% -$1.14M
TRI icon
281
Thomson Reuters
TRI
$46.4B
$8.75M 0.06%
69,345
-48,089
-41% -$5.99M
BNY
282
Bank of New York Mellon
BNY
$105B
$8.73M 0.06%
150,387
+83,167
+124% +$4.78M
LYFT icon
283
Lyft
LYFT
$6B
$8.55M 0.05%
166,509
+22,777
+16% +$1.07M
FIS icon
284
Fidelity National Information Services
FIS
$23.9B
$8.41M 0.05%
48,144
+767
+2% +$86.7K
DDOG icon
285
Datadog
DDOG
$97B
$8.34M 0.05%
46,839
-5,208
-10% -$884K
DLO icon
286
dLocal
DLO
$4.35B
$8.23M 0.05%
230,600
+60,400
+35% +$2.61M
TD icon
287
Toronto Dominion Bank
TD
$197B
$8.2M 0.05%
106,860
-4,870
-4% -$355K
CHTR icon
288
Charter Communications
CHTR
$17.3B
$8.07M 0.05%
12,380
-524
-4% -$357K
GE icon
289
GE Aerospace
GE
$370B
$7.96M 0.05%
135,215
-9,083
-6% -$571K
BCAB icon
290
BioAtla
BCAB
$5.33M
$7.94M 0.05%
8,093
MTN icon
291
Vail Resorts
MTN
$5.69B
$7.93M 0.05%
24,175
-5,751
-19% -$1.96M
ZGNX
292
DELISTED
Zogenix, Inc.
ZGNX
$7.81M 0.05%
480,497
-56,261
-10% -$824K
HHR
293
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$7.81M 0.05%
152,800
-25,800
-14% -$1.41M
MOR
294
DELISTED
MorphoSys AG American Depositary Shares
MOR
$7.71M 0.05%
268,835
CTMX icon
295
CytomX Therapeutics
CTMX
$703M
$7.62M 0.05%
1,760,922
-1,545,018
-47% -$9.05M
AGCO icon
296
AGCO
AGCO
$8.41B
$7.48M 0.05%
+64,471
New +$7.83M
INFY icon
297
Infosys
INFY
$51.1B
$6.98M 0.04%
275,633
+2,635
+1% +$61.2K
VNE
298
DELISTED
Veoneer, Inc.
VNE
$6.83M 0.04%
192,470
ZLAB icon
299
Zai Lab
ZLAB
$2.08B
$6.76M 0.04%
107,546
+3,231
+3% +$274K
DGX icon
300
Quest Diagnostics
DGX
$26B
$6.76M 0.04%
39,047
-29,502
-43% -$4.49M

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.